{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:41:47Z","timestamp":1790073707127,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2130,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/jto.0b013e3181c814e7","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T09:45:44Z","timestamp":1264499144000},"page":"220-228","source":"Crossref","is-referenced-by-count":206,"title":["Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer: Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation"],"prefix":"10.1016","volume":"5","author":[{"given":"Jean-Yves","family":"Douillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Tribodet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances A.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Veillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Le Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Spiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/JTO.0b013e3181c814e7_bib1","series-title":"GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0","author":"Ferlay","year":"2001"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib2","series-title":"General Thoracic Surgery","first-page":"1548","article-title":"Surgical treatment of non-small cell lung cancer","author":"Ponn","year":"2005"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib3","first-page":"119","article-title":"Pneumonectomy vs lobectomy in the treatment of pathologic N1 NSCLC: could the type of surgical resection dictate survival?","volume":"44","author":"Luzzi","year":"2003","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1634\/theoncologist.3-1-35","article-title":"Adjuvant chemotherapy for resected non-small-cell carcinoma of the lung: why we still don't know","volume":"3","author":"George","year":"1998","journal-title":"Oncologist"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib6","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2004.01.153","article-title":"Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials","volume":"22","author":"Hotta","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jtcvs.2004.04.027","article-title":"Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis","volume":"128","author":"Sedrakyan","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib8","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.athoracsur.2005.04.045","article-title":"The Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Postoperative chemotherapy in nonsmall cell lung cancer: a systematic review","volume":"81","author":"Alam","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2005.01.002","article-title":"Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature","volume":"49","author":"Berghmans","year":"2005","journal-title":"Lung cancer"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib10","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib11","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejcts.2004.03.041","article-title":"Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the big lung trial","volume":"26","author":"Waller","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"Suppl 13","key":"10.1097\/JTO.0b013e3181c814e7_bib13","doi-asserted-by":"crossref","first-page":"5017s","DOI":"10.1158\/1078-0432.CCR-05-9006","article-title":"Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial","volume":"11","author":"Dunant","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/jnci\/djg059","article-title":"Adjuvant Lung Project Italy\/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigators. Randomized study of adjuvant chemotherapy for completly resected stage I, II, or IIIA non-small-cell lung cancer","volume":"95","author":"Scagliotti","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 13","key":"10.1097\/JTO.0b013e3181c814e7_bib17","doi-asserted-by":"crossref","first-page":"5011s","DOI":"10.1158\/1078-0432.CCR-05-9009","article-title":"The ALPI Trial: the Italian\/European experience with adjuvant chemotherapy in resectable non-small lung cancer","volume":"11","author":"Scagliotti","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"16","author":"Schemper","year":"1996","journal-title":"Control clin trials"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib19","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM199511303332202","article-title":"Effects of radiotherapy and surgery in early breast cancer. An overview of randomized trials. Early Breast Cancer Trialists' Collaborative Group","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib21","first-page":"1","article-title":"Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 death among 75,000 women","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib22","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J Clin Oncol"},{"issue":"Suppl 397","key":"10.1097\/JTO.0b013e3181c814e7_bib23","article-title":"Surgery and adjuvant chemotherapy (CT) versus surgery alone in non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs)","volume":"25","author":"Stewart","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/JTO.0b013e3181c814e7_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijrobp.2008.01.044","volume":"72","author":"Douillard","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415322802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086415322802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T21:43:24Z","timestamp":1590529404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086415322802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1556086415322802"],"URL":"https:\/\/doi.org\/10.1097\/jto.0b013e3181c814e7","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}